Expression of a novel mycobacterial phosphodiesterase successfully lowers cAMP levels resulting in reduced tolerance to cell wall-targeting antimicrobials. (2022)
Attributed to:
MRC Centre for Molecular Bacteriology and Infection
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jbc.2022.102151
PubMed Identifier: 35718063
Publication URI: http://europepmc.org/abstract/MED/35718063
Type: Journal Article/Review
Volume: 298
Parent Publication: The Journal of biological chemistry
Issue: 8
ISSN: 0021-9258